LP
TBIO

LMR Partners’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

LMR Partners’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,850
Closed -$733K – 1234
2021
Q2 		$733K Buy
+1,850
New +$654K 0.01% 606

Other funds holding TBIO

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

LMR Partners's TBIO Position: Q3 2021 in Review

LMR Partners sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,850 shares — an estimated $733K sold.

LMR Partners first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $733K in Q2 2021. 43 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • LMR Partners reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • LMR Partners sold 1,850 Telesis Bio, Inc. Common Stock shares in Q3 2021, an estimated $733K.
  • LMR Partners first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • LMR Partners's Telesis Bio, Inc. Common Stock position peaked at $733K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2021.

Based on LMR Partners's 13F filing for Q3 2021, filed 15 Nov 2021.